| Literature DB >> 33521879 |
Dimitri Sneiders1, Gijs H J de Smet2, Floris den Hartog1, Yagmur Yurtkap1, Anand G Menon3, Johannes Jeekel4, Gert-Jan Kleinrensink4, Johan F Lange1,3, Jean-François Gillion5.
Abstract
BACKGROUND: Patients with a re-recurrent hernia may account for up to 20% of all incisional hernia (IH) patients. IH repair in this population may be complex due to an altered anatomical and biological situation as a result of previous procedures and outcomes of IH repair in this population have not been thoroughly assessed. This study aims to assess outcomes of IH repair by dedicated hernia surgeons in patients who have already had two or more re-recurrences.Entities:
Year: 2021 PMID: 33521879 PMCID: PMC8026468 DOI: 10.1007/s00268-021-05952-5
Source DB: PubMed Journal: World J Surg ISSN: 0364-2313 Impact factor: 3.352
Patient characteristics
| Unmatched sample | Propensity score matched sample | |||||
|---|---|---|---|---|---|---|
| control | ≥ 2 re-recurrences | P | control | ≥ 2 re-recurrences | P | |
| 763 | 76 | 219 | 73 | |||
| 378 (50) | 33 (43) | 0.309 | 94 (43) | 32 (44) | 0.891 | |
| 66 (56–74) | 66 (57–71) | 0.392 | 64 (55–73) | 66 (58–71) | 0.854 | |
| 28 (25–32) | 31 (28–34) | 29 (26–35) | 31 (28–34) | 0.079 | ||
| | 561 (74) | 52 (68) | 0.266 | 152 (69) | 50 (68) | 0.911 |
| | 194 (26) | 24 (32) | 64 (29) | 23 (32) | ||
| 133 (18) | 19 (25) | 0.108 | 55 (26) | 18 (25) | 0.874 | |
| NA | NA | |||||
| | NA | 47 (62) | NA | 45 (62) | ||
| | NA | 29 (38) | NA | 28 (38) | ||
| | 406 (59) | 35 (52) | 0.279 | 102 (51) | 34 (53) | 0.972 |
| | 158 (23) | 22 (33) | 63 (32) | 20 (31) | ||
| | 25 (4) | 1 (2) | 5 (3) | 1 (2) | ||
| | 100 (15) | 9 (13) | 29 (15) | 9 (14) | ||
| | 560 (76) | 59 (79) | 168 (79) | 58 (81) | 0.887 | |
| | 129 (18) | 6 (8) | 16 (8) | 6 (8) | ||
| | 45 (6) | 10 (13) | 28 (13) | 8 (11) | ||
| < | 372 (51) | 21 (28) | 61 (29) | 21 (30) | 0.927 | |
| | 249 (34) | 34 (47) | 102 (48) | 32 (46) | ||
| > | 105 (15) | 18 (25) | 48 (23) | 17 (24) | ||
| | 299 (40) | 24 (32) | 65 (30) | 24 (33) | 0.912 | |
| | 372 (49) | 35 (47) | 111 (52) | 35 (49) | ||
| | 16 (2) | 4 (5) | 7 (3) | 2 (3) | ||
| | 66 (9) | 12 (16) | 32 (15) | 11 (15) | ||
| 29 (4) | 6 (8) | 0.090 | 19 (9) | 5 (7) | 0.622 | |
| 110 (15) | 9 (12) | 0.567 | 32 (15) | 9 (13) | 0.655 | |
| | 685 (90) | 62 (82) | 183 (84) | 60 (85) | 0.981 | |
| | 45 (6) | 10 (13) | 29 (13) | 10 (14) | ||
| | 23 (3) | 1 (1) | 2 (1) | 1 (1) | ||
| | 5 (1) | 3 (4) | 5 (2) | 2 (3) | ||
| 2 (1–2) | 1 (1–2) | 0.632 | 1 (1–2) | 1 (1–2) | 0.923 | |
Continuous variables are presented as median and interquartile range, and discrete variables are presented as absolute number and percentage. BMI: body mass index, ASA: American society of anesthesiology, EHS: European hernia society, IPOM: intraperitoneal onlay mesh, NA: not applicable
Surgical outcomes
| Unmatched sample | Propensity score matched sample | |||||
|---|---|---|---|---|---|---|
| Control | ≥ 2 re-recurrences | P | Control | ≥ 2 re-recurrences | P | |
| 763 | 76 | 219 | 73 | |||
| 121 (16) | 19 (25) | 51 (23) | 18 (25) | 0.811 | ||
| | 28 (4) | 4 (5) | 0.121 | 14 (6) | 4 (6) | |
| | 25 (3) | 4 (6) | 0.361 | 11 (5) | 4 (6) | |
| 173 (23) | 10 (14) | 0.065 | 44 (21) | 9 (13) | 0.123 | |
| 744 | 73 | 197 | 64 | |||
| | 130 (18) | 10 (14) | 0.175 | 24 (11) | 8 (13) | 0.61 |
| | 9 (1) | 0 | 5 (3) | 0 | ||
| ≥ | 29 (4) | 0 | 3 (2) | 0 | ||
| 740 | 71 | 210 | 71 | |||
| | 122 (17) | 6 (9) | 0.076 | 36 (17) | 6 (8.5) | 0.081 |
| | 69 (9) | 3 (4) | 0.138 | 13 (6) | 2 (3) | 0.274 |
Outcomes are presented as absolute numbers and percentage. * Outcome was not available in all patients. IH: incisional hernia
Functional outcomes
| Unmatched sample | Propensity score matched sample | |||||
|---|---|---|---|---|---|---|
| control | ≥ 2 re-recurrences | P | control | ≥ 2 re-recurrences | P | |
| 634 | 62 | 172 | 59 | |||
| 69 (11) | 11 (18) | 0.102 | 24 (14) | 10 (17) | 0.51 | |
| 92 (14) | 13 (21) | 0.164 | 29 (16) | 12 (20) | 0.38 | |
| 147 (23) | 20 (32) | 0.097 | 44 (24) | 18 (31) | 0.344 | |
| 33 (5) | 7 (11) | 11 (6) | 7 (12) | 0.143 | ||
| 7 (1) | 3 (5) | 3 (2) | 2 (3) | 0.419 | ||
| 631 | 62 | 179 | 59 | |||
| 37 (6) | 3 (5) | 0.484 | 11 (6) | 3 (5) | 0.803 | |
| 22 (4) | 4 (6) | 6 (3) | 3 (5) | |||
Outcomes are presented as absolute numbers and percentage. * Outcome was not available in all patients. VAS: visual analogue scale. Moderate limitations: difficulties in several daily activities. Severe limitations: some daily activities not possible